Category Archives: "News"

Multiple sclerosis therapy can ‘reverse disease’
A radical treatment can halt the progression of multiple sclerosis and even reverse symptoms of the autoimmune disease, research [...]
Immune ablation before stem cell transplant works in multiple sclerosis
A myeloablative protocol similar to those used in hematologic malignancies is feasible as a prelude to autologous hemapoietic stem cell [...]
Nine CMSC 2016 Annual Meeting exclusive interviews you can’t miss
This year, Multiple Sclerosis News Today offered expanded coverage of the 2016 Annual Meeting of the Consortium of Multiple Sclerosis [...]
CMSC 2016 Annual Meeting – metabolism in multiple sclerosis and the role of mitochondrial dysfunction
One June 3, a workshop titled “Metabolism in MS and Related Conditions” was presented at the 2016 Annual Meeting of the Consortium of [...]
CMSC 2016 Annual Meeting – tai chi shown to improve balance and strength in multiple sclerosis patients
Researchers at Texas Woman’s University identified tai chi as a beneficial therapy for multiple sclerosis (MS) patients with impaired [...]
CMSC 2016 Annual Meeting – multiple sclerosis rehab clinical practice guideline help patients achieve excellent results
Two case reports from the Sheltering Arms Physical Rehabilitation Centers presented at the Consortium of Multiple Sclerosis Centers [...]
CMSC 2016 Annual Meeting – multiple sclerosis patients’ speech limitations and difficulty in swallowing may be measured
Researchers from Mount Sinai Rehabilitation Hospital found that patients with multiple sclerosis (MS) who complain of speech limitations [...]
CMSC 2016 Annual Meeting – aging multiple sclerosis patients experience greater physical dysfunction
The population of older people with multiple sclerosis (MS) is larger than ever and likely to continue growing, but the combination of old [...]
CMSC 2016 Annual Meeting – physical training with assistive devices improves mobility for multiple sclerosis patients
The use of assistive devices is ineffective for multiple sclerosis (MS) patients, a study recently presented at the Consortium of Multiple [...]
CMSC 2016 Annual Meeting – Fingolimod (Gilenya) offers consistent health benefits in RRMS patients
Researchers at the Swedish Neuroscience Institute in Washington and Novartis Pharma revealed that Gilenya (fingolimod) induced a [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last